Product
THR-149 + Aflibercept
1 clinical trial
3 indications
Indication
Diabetes MellitusIndication
Diabetic RetinopathyIndication
Diabetic Macular EdemaClinical trial
A Phase 2, Randomised, Multicentre Study to Assess the Dose Level of Multiple THR-149 Injections and to Evaluate the Efficacy and Safety of THR-149 Versus Aflibercept for the Treatment of Diabetic Macular Oedema (DME)Status: Completed, Estimated PCD: 2023-09-28